Fig. 2.
Cumulative survival rates for a SOR vs. CON and b mSOR vs. mCON. CON transcatheter arterial chemoembolization, mCON matched transcatheter arterial chemoembolization, mSOR matched sorafenib, SOR sorafenib
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.